Asthma - Children
|
Most Recent Report |
Past Reports |
Rate: 11%
* 2012 Report (7/1/2011-6/30/2012 DOS) (* Avg: 37%)
|
| Rate: 6%
* 2011 Report (7/1/2010-6/30/2011 DOS) (* Avg: 24%)
|
|
|
Asthma - Adults
|
Most Recent Report |
Past Reports |
Rate: 17%
* 2012 Report (7/1/2011-6/30/2012 DOS) (* Avg: 30%)
|
| Rate: 27%
* 2011 Report (7/1/2010-6/30/2011 DOS) (* Avg: 16%)
|
|
|
Colorectal Cancer
|
Most Recent Report |
Past Reports |
Rate: 66%
* 2012 Report (7/1/2011-6/30/2012 DOS) (* Avg: 68%)
|
| Rate: 58%
* 2011 Report (7/1/2010-6/30/2011 DOS) (* Avg: 64%)
|
|
|
Response at 6 Months |
Most Recent Report |
Rate: 6%
* July 01 2011 to June 30 2012 (* Avg: 12%)
|
| Rate: 12%
* July 01 2010 to June 30 2011 (* Avg: 10%)
| Rate: 9%
* July 01 2009 to June 30 2010 (* Avg: 9%)
|
|
Response at 12 Months |
Most Recent Report |
Rate: 9%
* Jan 1 2011 - Dec 31 2011 (* Avg: 9%)
|
| Rate: 9%
* Jan 1 2010 - Dec 31 2010 (* Avg: 9%)
| Rate: 13%
* Jan 1 2009 - Dec 31 2009 (* Avg: 8%)
|
|
Remission at 6 Months |
Most Recent Report |
Rate: 4%
* July 01 2011 to June 30 2012 (* Avg: 7%)
|
| Rate: 6%
* July 01 2010 to June 30 2011 (* Avg: 6%)
| Rate: 3%
* July 01 2009 to June 30 2010 (* Avg: 5%)
| Rate: 7%
* July 01 2008 - June 30 2009 (* Avg: 6%)
| Rate: 2%
* Jan 01 - Jun 30 2008 (* Avg: 5%)
|
|
Remission at 12 Months |
Most Recent Report |
Rate: 6%
* Jan 1 2011 - Dec 31 2011 (* Avg: 5%)
|
| Rate: 9%
* Jan 1 2010 - Dec 31 2010 (* Avg: 5%)
| Rate: 8%
* Jan 1 2009 - Dec 31 2009 (* Avg: 5%)
| Rate: 3%
* Jan 1 2008 to Dec 31 2008 (* Avg: 5%)
|
|
Utilization of the PHQ-9 |
Most Recent Report |
Legend  | Clinic Average |  | State Average |
|
Diabetes
|
Most Recent Report |
Past Reports |
Rate: 29%
* 2013 Report (2012 DOS) (* Avg: 38%)
|
| Rate: 30%
* 2012 Report (2011 DOS) (* Avg: 38%)
| Rate: 35%
* 2011 Report (2010 DOS) (* Avg: 37%)
| Rate: 20%
* 2010 Report (2009 DOS) (* Avg: 25%)
| Rate: 22%
* 2009 Report (2008 DOS) (* Avg: 19%)
| Rate: 32%
* 2008 Report (2007 DOS) (* Avg: 17%)
| Rate: 30%
* 2007 Report (* Avg: 14%)
|
|
|
Diabetes - Blood Pressure
|
Most Recent Report |
Past Reports |
Rate: 84%
* 2013 Report (2012 DOS) (* Avg: 84%)
|
| Rate: 80%
* 2012 Report (2011 DOS) (* Avg: 84%)
| Rate: 71%
* 2011 Report (2010 DOS) (* Avg: 83%)
| Rate: 45%
* 2010 Report (2009 DOS) (* Avg: 58%)
| Rate: 57%
* 2009 Report (2008 DOS) (* Avg: 56%)
| Rate: 61%
* 2008 Report (2007 DOS) (* Avg: 54%)
|
|
|
Diabetes - LDL Control
|
Most Recent Report |
Past Reports |
Rate: 45%
* 2013 Report (2012 DOS) (* Avg: 62%)
|
| Rate: 43%
* 2012 Report (2011 DOS) (* Avg: 62%)
| Rate: 49%
* 2011 Report (2010 DOS) (* Avg: 60%)
| Rate: 49%
* 2010 Report (2009 DOS) (* Avg: 57%)
| Rate: 55%
* 2009 Report (2008 DOS) (* Avg: 58%)
| Rate: 64%
* 2008 Report (2007 DOS) (* Avg: 56%)
|
|
|
Diabetes - HbA1c Control
|
Most Recent Report |
Past Reports |
Rate: 74%
* 2013 Report (2012 DOS) (* Avg: 74%)
|
| Rate: 81%
* 2012 Report (2011 DOS) (* Avg: 75%)
| Rate: 74%
* 2011 Report (2010 DOS) (* Avg: 75%)
| Rate: 84%
* 2010 Report (2009 DOS) (* Avg: 72%)
| Rate: 75%
* 2009 Report (2008 DOS) (* Avg: 55%)
| Rate: 81%
* 2008 Report (2007 DOS) (* Avg: 57%)
|
|
|
Diabetes - Tobacco-free
|
Most Recent Report |
Past Reports |
Rate: 87%
* 2013 Report (2012 DOS) (* Avg: 84%)
|
| Rate: 89%
* 2012 Report (2011 DOS) (* Avg: 84%)
| Rate: 89%
* 2011 Report (2010 DOS) (* Avg: 83%)
| Rate: 88%
* 2010 Report (2009 DOS) (* Avg: 83%)
| Rate: 90%
* 2009 Report (2008 DOS) (* Avg: 83%)
| Rate: 91%
* 2008 Report (2007 DOS) (* Avg: 83%)
|
|
|
Diabetes - Daily Aspirin Use
|
Most Recent Report |
Past Reports |
Rate: 100%
* 2013 Report (2012 DOS) (* Avg: 99%)
|
| Rate: 100%
* 2012 Report (2011 DOS) (* Avg: 99%)
| Rate: 100%
* 2011 Report (2010 DOS) (* Avg: 99%)
| Rate: 87%
* 2010 Report (2009 DOS) (* Avg: 86%)
| Rate: 83%
* 2009 Report (2008 DOS) (* Avg: 87%)
| Rate: 99%
* 2008 Report (2007 DOS) (* Avg: 87%)
|
|
|
Health Information Technology |
|
Vascular Disease
|
Most Recent Report |
Past Reports |
Rate: 50%
* 2013 Report (2012 DOS) (* Avg: 49%)
|
| Rate: 60%
* 2012 Report (2011 DOS) (* Avg: 49%)
| Rate: 37%
* 2011 Report (2010 DOS) (* Avg: 40%)
| Rate: 23%
* 2009 Report (2008 DOS) (* Avg: 34%)
|
|
|
Vascular Disease - Blood Pressure
|
Most Recent Report |
Past Reports |
Rate: 85%
* 2013 Report (2012 DOS) (* Avg: 84%)
|
| Rate: 91%
* 2012 Report (2011 DOS) (* Avg: 84%)
| Rate: 69%
* 2011 Report (2010 DOS) (* Avg: 67%)
| Rate: 59%
* 2009 Report (2008 DOS) (* Avg: 58%)
|
|
|
Vascular Disease - LDL Control
|
Most Recent Report |
Past Reports |
Rate: 63%
* 2013 Report (2012 DOS) (* Avg: 67%)
|
| Rate: 69%
* 2012 Report (2011 DOS) (* Avg: 67%)
| Rate: 63%
* 2011 Report (2010 DOS) (* Avg: 65%)
| Rate: 57%
* 2009 Report (2008 DOS) (* Avg: 65%)
|
|
|
Vascular Disease - Tobacco-free
|
Most Recent Report |
Past Reports |
Rate: 90%
* 2013 Report (2012 DOS) (* Avg: 83%)
|
| Rate: 91%
* 2012 Report (2011 DOS) (* Avg: 83%)
| Rate: 88%
* 2011 Report (2010 DOS) (* Avg: 83%)
| Rate: 86%
* 2009 Report (2008 DOS) (* Avg: 82%)
|
|
|
Vascular Disease - Daily Aspirin Use
|
Most Recent Report |
Past Reports |
Rate: 85%
* 2013 Report (2012 DOS) (* Avg: 96%)
|
| Rate: 91%
* 2012 Report (2011 DOS) (* Avg: 95%)
| Rate: 84%
* 2011 Report (2010 DOS) (* Avg: 94%)
| Rate: 77%
* 2009 Report (2008 DOS) (* Avg: 93%)
|
|
|